The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.

Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

SOHO Italy 2020

2nd Annual Society of Hematological Oncology (SOHO) Italian Meeting
22–24 September 2020 | Rome, Italy

There’s only a week to go until #IACH2021! Here at @VJHemOnc we’ll be covering the event by bringing you all the latest insights from leaders in the field of #HemOnc 🙌

Make sure to visit 👉http://VJHemOnc.com👈 to stay up to date!

@TheIACH @Mohty_EBMT #MMsm #LEUsm #LYMsm

#VJSounds | CAR-T versus bispecific antibodies: replacing ASCT in #Myeloma

🎧 Listen to our latest podcast here: http://ow.ly/3qVB50GbFLW

w/ Hermann Einsele (@H_Einsele) and Parameswaran Hari 👨‍⚕️

@VJHemOnc #MMsm #MultipleMyeloma #HemOnc #ImmunoOncology

LAST CALL FOR ABSTRACTS! Today is the last day, Soho Italy invites all #hemonc investigators to submit an abstract at https://soho.abstracts.it/ ! Do not miss the opportunity to be part of the annual conference #sohoitaly2021 @VuMedi @VJHemOnc
#abstract #abstractsubmission

Jorge Castillo (@DanaFarber) discuss the results of a Phase I trial investigating the CXCR4 antagonist ulocuplumab + ibrutinib in CXCR4-mutated Waldenström’s macroglobulinemia

💻 Watch: http://ow.ly/1jI850G9A5O

@SocietyofHemOnc #SOHO2021 #LYMsm #Lymphoma #CancelBloodCancer #BCAM

#iwCLL2021 starts today! 🙌

From therapeutic strategies to patient experiences, we’ll bring you the latest coverage! 🎥

Click for updates 👉http://VJHemOnc.com👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia

Load More...

SOHO Italy 2020

2nd Annual Society of Hematological Oncology (SOHO) Italian Meeting
22–24 September 2020 | Rome, Italy

The 2nd Society of Hematological Oncology (SOHO) Italian three-day meeting brings together leading SOHO experts and Italian researchers in acute leukemias, MPNs, and MDS, with the aims of consolidating the Italian Hematology-SOHO partnership.

Highlights from this year’s SOHO Italy Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

There’s only a week to go until #IACH2021! Here at @VJHemOnc we’ll be covering the event by bringing you all the latest insights from leaders in the field of #HemOnc 🙌

Make sure to visit 👉http://VJHemOnc.com👈 to stay up to date!

@TheIACH @Mohty_EBMT #MMsm #LEUsm #LYMsm

#VJSounds | CAR-T versus bispecific antibodies: replacing ASCT in #Myeloma

🎧 Listen to our latest podcast here: http://ow.ly/3qVB50GbFLW

w/ Hermann Einsele (@H_Einsele) and Parameswaran Hari 👨‍⚕️

@VJHemOnc #MMsm #MultipleMyeloma #HemOnc #ImmunoOncology

LAST CALL FOR ABSTRACTS! Today is the last day, Soho Italy invites all #hemonc investigators to submit an abstract at https://soho.abstracts.it/ ! Do not miss the opportunity to be part of the annual conference #sohoitaly2021 @VuMedi @VJHemOnc
#abstract #abstractsubmission

Jorge Castillo (@DanaFarber) discuss the results of a Phase I trial investigating the CXCR4 antagonist ulocuplumab + ibrutinib in CXCR4-mutated Waldenström’s macroglobulinemia

💻 Watch: http://ow.ly/1jI850G9A5O

@SocietyofHemOnc #SOHO2021 #LYMsm #Lymphoma #CancelBloodCancer #BCAM

#iwCLL2021 starts today! 🙌

From therapeutic strategies to patient experiences, we’ll bring you the latest coverage! 🎥

Click for updates 👉http://VJHemOnc.com👈

@VJHemOnc @iwCLL #CLLsm #LEUsm #Leukemia

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter